$OPBK
OP Bancorp Stock $opbk

$opbk Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023018156 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$573.0K	$418.0K
YoY Change	-97.16%	-97.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$338.0K	$371.0K
YoY Change	-0.88%	-4.87%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$12.85M	$10.70M
YoY Change	1102.06%	1536.39%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$8.557M	$10.62M
YoY Change	-28.33%	-7.7%
Income Tax	$2.500M	$3.100M
% Of Pretax Income	29.22%	29.2%
Net Earnings	$6.091M	$7.534M
YoY Change	-28.17%	-7.58%
Net Earnings / Revenue	1063.0%	1802.39%
Basic Earnings Per Share	$0.39	$0.48
Diluted Earnings Per Share	$0.39	$0.48
COMMON SHARES
Basic Shares Outstanding	15.17M shares	15.34M shares
Diluted Shares Outstanding	15.17M shares	15.31M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$143.8M	$181.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$5.093M	$4.647M
YoY Change	13.35%	1.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.40M	$12.32M
YoY Change	0.22%	13.24%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.152B	$2.171B
YoY Change	11.24%	16.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.400M	$5.751M
YoY Change	1435.95%	949.45%
Accrued Expenses	$10.50M	$10.51M
YoY Change	12.48%	6.85%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$19.90M	$16.26M
YoY Change	100.06%	56.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$13.50M	$15.73M
YoY Change	2.43%	1.07%
Total Long-Term Liabilities	$13.50M	$15.73M
YoY Change	2.43%	1.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.90M	$16.26M
Total Long-Term Liabilities	$13.50M	$15.73M
Total Liabilities	$1.968B	$1.987B
YoY Change	11.51%	17.01%
SHAREHOLDERS EQUITY
Retained Earnings	$114.2M	$109.9M
YoY Change	23.22%	28.26%
Common Stock	$87.76M	$89.53M
YoY Change	-0.05%	2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$183.8M	$183.8M
YoY Change
Total Liabilities & Shareholders Equity	$2.152B	$2.171B
YoY Change	11.24%	16.45%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$6.091M	$7.534M
YoY Change	-28.17%	-7.58%
Depreciation, Depletion And Amortization	$338.0K	$371.0K
YoY Change	-0.88%	-4.87%
Cash From Operating Activities	$9.110M	$44.64M
YoY Change	-58.6%	254.31%
INVESTING ACTIVITIES
Capital Expenditures	$750.0K	$618.0K
YoY Change	-385.17%	13.39%
Acquisitions
YoY Change
Other Investing Activities	-$22.03M	-$12.84M
YoY Change	-74.69%	-90.41%
Cash From Investing Activities	-$22.77M	-$13.46M
YoY Change	-73.92%	-89.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-24.08M	$67.35M
YoY Change	-135.4%	-50.63%
NET CHANGE
Cash From Operating Activities	9.110M	$44.64M
Cash From Investing Activities	-22.77M	-$13.46M
Cash From Financing Activities	-24.08M	$67.35M
Net Change In Cash	-37.74M	$98.54M
YoY Change	-1486.99%	578.77%
FREE CASH FLOW
Cash From Operating Activities	$9.110M	$44.64M
Capital Expenditures	$750.0K	$618.0K
Free Cash Flow	$8.360M	$44.03M
YoY Change	-62.45%	265.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001722010
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#InterestReceivable
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#InterestReceivable
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38437
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	OP BANCORP
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3114676
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 Wilshire Blvd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15171464	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	181509000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82972000	usd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90017
CY2023Q1	dei	City Area Code CityAreaCode	213
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	892-9999
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2023Q1	dei	Trading Symbol TradingSymbol	OPBK
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	212767000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	209809000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	12172000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	12098000	usd
CY2023Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	7534000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	44335000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20814000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1671671000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1659051000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4647000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4400000	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	7302000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	7180000	usd
CY2023Q1	us-gaap	Servicing Asset ServicingAsset	12898000	usd
CY2022Q4	us-gaap	Servicing Asset ServicingAsset	12759000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	21762000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	21613000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12323000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14316000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9459000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9097000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	16550000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	16867000	usd
CY2023Q1	us-gaap	Assets Assets	2170594000	usd
CY2022Q4	us-gaap	Assets Assets	2094497000	usd
CY2023Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	643902000	usd
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	701584000	usd
CY2023Q1	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	436796000	usd
CY2022Q4	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	526321000	usd
CY2023Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	411648000	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	356197000	usd
CY2023Q1	opbk	Interest Bearing Deposit Other Time Deposit InterestBearingDepositOtherTimeDeposit	412472000	usd
CY2022Q4	opbk	Interest Bearing Deposit Other Time Deposit InterestBearingDepositOtherTimeDeposit	301669000	usd
CY2023Q1	us-gaap	Deposits Deposits	1904818000	usd
CY2022Q4	us-gaap	Deposits Deposits	1885771000	usd
CY2023Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	50000000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5751000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2771000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	10513000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10213000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	15731000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	18826000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1986813000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1917581000	usd
CY2023Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15286558	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15286558	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15270344	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15270344	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	79475000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	79326000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10056000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9743000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	109908000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	105690000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15658000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17843000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	183781000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	176916000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2170594000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2094497000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	26011000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17257000	usd
CY2023Q1	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	1566000	usd
CY2022Q1	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	530000	usd
CY2023Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1017000	usd
CY2022Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	157000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	28594000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	17944000	usd
CY2023Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	10382000	usd
CY2022Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	654000	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	320000	usd
CY2022Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	10702000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	654000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17892000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17290000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-338000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	341000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	18230000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	16949000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	388000	usd
CY2023Q1	opbk	Loan Servicing Fees Net Of Amortization LoanServicingFeesNetOfAmortization	846000	usd
CY2022Q1	opbk	Loan Servicing Fees Net Of Amortization LoanServicingFeesNetOfAmortization	447000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2570000	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	3238000	usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	461000	usd
CY2022Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	143000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	4295000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	4216000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7252000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5657000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	1570000	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	1378000	usd
CY2023Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	550000	usd
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	493000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3083000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	359000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	324000	usd
CY2023Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	467000	usd
CY2022Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	207000	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	162000	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	189000	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	161000	usd
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	177000	usd
CY2023Q1	opbk	Noninterest Expense Foundation Donation And Other Contributions NoninterestExpenseFoundationDonationAndOtherContributions	753000	usd
CY2022Q1	opbk	Noninterest Expense Foundation Donation And Other Contributions NoninterestExpenseFoundationDonationAndOtherContributions	815000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	634000	usd
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	422000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	11908000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	9662000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10617000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11503000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3351000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7534000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8152000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7534000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8152000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	3104000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-8638000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	919000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-2554000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2185000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6084000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9719000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2068000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	176916000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7534000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2185000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	709000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	324000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	76990	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	571000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	571000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2023Q1	us-gaap	Dividends Cash DividendsCash	1832000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	183781000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	165222000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8152000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6084000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	215000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2022Q1	us-gaap	Dividends Cash DividendsCash	1514000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	165991000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7534000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8152000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-338000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	341000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	371000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	390000	usd
CY2023Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	72000	usd
CY2022Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	216000	usd
CY2023Q1	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	961000	usd
CY2022Q1	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	1171000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	984000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1442000	usd
CY2023Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	361000	usd
CY2022Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	187000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	324000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	215000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1074000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2570000	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	3238000	usd
CY2023Q1	opbk	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	149000	usd
CY2022Q1	opbk	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	63000	usd
CY2023Q1	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	54000	usd
CY2022Q1	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-173000	usd
CY2023Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	9666000	usd
CY2022Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	28900000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	47937000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	35323000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	122000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	28983000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	20000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	618000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-108000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-443000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-216000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2980000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-10000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3531000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-319000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44643000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12600000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	640000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	32631000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5721000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9392000	usd
CY2023Q1	opbk	Payments To Acquire Loans And Servicing Rights PaymentsToAcquireLoansAndServicingRights	12142000	usd
CY2022Q1	opbk	Payments To Acquire Loans And Servicing Rights PaymentsToAcquireLoansAndServicingRights	81552000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5647000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	545000	usd
CY2023Q1	opbk	Payments For Proceeds From Investment In Low Income Housing Partnerships PaymentsForProceedsFromInvestmentInLowIncomeHousingPartnerships	113000	usd
CY2022Q1	opbk	Payments For Proceeds From Investment In Low Income Housing Partnerships PaymentsForProceedsFromInvestmentInLowIncomeHousingPartnerships	187000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13459000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134506000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	19047000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	137937000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	720000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	50000000	usd
CY2022Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	571000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1832000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1514000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	67353000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136423000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	98537000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14517000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82972000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115459000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181509000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129976000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7722000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	664000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	849000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	opbk	Number Of Full Service Branches NumberOfFullServiceBranches	10	branch
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	21165000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	446000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	234996000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	439000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	22668000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	212767000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	235142000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25334000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	209809000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1467000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1411000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4503000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	4120000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	229026000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	207236000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	234996000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	212767000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	53857000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1215000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	124982000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	21453000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	178839000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	22668000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	107667000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5373000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	95021000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	19961000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	202688000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	25334000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3400000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3300000	usd
CY2023Q1	opbk	Allowance For Credit Loss Reversion Period Baseline Scenario AllowanceForCreditLossReversionPeriodBaselineScenario	P1Y
CY2023Q1	opbk	Allowances For Credit Loss Reversion Period Adverse Scenario AllowancesForCreditLossReversionPeriodAdverseScenario	P2Y
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	54000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-173000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1692485000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20814000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1671671000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1659051000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	70000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-160000	usd
CY2023Q1	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	0	usd
CY2022Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Credit Losses on Loans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs a modeled approach that takes into account current and future economic conditions to estimate lifetime expected losses on a collective basis. With the adoption of CECL, the Company elected not to consider accrued interest receivable in its estimated credit losses because the Company writes off uncollectible accrued interest receivable in a timely manner. The Company considers writing off accrued interest amounts once the amounts become 90 days past due to be considered within a timely manner. The Company has elected to write off accrued interest receivable by reversing interest income. The Company uses transition matrices to develop the Probability of Default ("PD") and Loss Given Default ("LGD") approach, incorporating quantitative factors and qualitative considerations in the calculation of the allowance for credit losses for collectively assessed loans. The model provides forecasts of PD and LGD based on national unemployment rates using regression analysis. The Company incorporates future economic conditions using a weighted multiple scenario approach: baseline and adverse. The Company applies a reasonable and supportable period of one year for the baseline scenario and two years for the adverse scenario, after which loss assumptions revert to historical loss information through a one-year reversion period for the baseline scenario and a two-year reversion period for the adverse scenario. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to quantify the credit risk impact of other trends and changes within the loan portfolio, the Company utilizes qualitative adjustments to the modeled estimated loss approaches. The parameters for making adjustments are established under a Credit Risk Matrix that provides different possible scenarios for each of the factors listed below. The Credit Risk Matrix and the possible scenarios enable the Bank to qualitatively adjust the loss rates. This matrix considers the following nine factors, which are patterned after the guidelines provided under the Federal Financial Institutions Examination Council Interagency Policy Statement on the Allowance for Credit Losses, updated to reflect the adoption of CECL:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in lending policies and procedures, including changes in underwriting standards and practices for collection, charge-offs, and recoveries;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Actual and expected changes in national and local economic and business conditions and developments in which the institution operates that affect the collectivity of loans;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the nature and volume of the loan portfolio;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the experience, ability, and depth of lending management and staff;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the volume and severity of past due loans, the volume of nonaccrual loans, and the volume and severity of adversely classified loans;</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the quality of the credit review function; </span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• Changes in the value of the underlying collateral for loans that are not collateral-dependent; </span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• The existence, growth, and effect of any concentrations of credit, and</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• The effect of other external factors, such as the regulatory, legal and technological environments; competition; and events such as natural disasters.</span></div>
CY2023Q1	opbk	Allowance For Credit Loss Reversion Period Baseline Scenario AllowanceForCreditLossReversionPeriodBaselineScenario	P1Y
CY2023Q1	opbk	Allowances For Credit Loss Reversion Period Adverse Scenario AllowancesForCreditLossReversionPeriodAdverseScenario	P2Y
CY2023Q1	opbk	Financing Receivable Allowance For Credit Loss Number Of Matrix Factors FinancingReceivableAllowanceForCreditLossNumberOfMatrixFactors	9	factor
CY2023Q1	opbk	Allowance For Credit Losses Non Accrual Loan AllowanceForCreditLossesNonAccrualLoan	250000	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	250000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Credit Loss Impact Of Cecl Adoption FinancingReceivableExcludingAccruedInterestCreditLossImpactOfCECLAdoption	1924000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	-258000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	116000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	23000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20814000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	16123000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	546000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	14000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	17000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	16672000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	258000	usd
CY2023Q1	opbk	Financing Receivable Allowance For Credit Loss Recovery Off Balance Sheet Commitments FinancingReceivableAllowanceForCreditLossRecoveryOffBalanceSheetCommitments	80000	usd
CY2023Q1	opbk	Financing Receivable Allowance For Credit Loss Recovery Including Off Balance Sheet Commitments FinancingReceivableAllowanceForCreditLossRecoveryIncludingOffBalanceSheetCommitments	338000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	293000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	20521000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	20814000	usd
CY2023Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	2209000	usd
CY2023Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1690276000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1692485000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	279000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	18962000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19241000	usd
CY2022Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	702000	usd
CY2022Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1677590000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	702000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	423000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	279000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	279000	usd
CY2022Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	1127000	usd
CY2022Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	2555000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance	1557000	usd
CY2023Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	4112000	usd
CY2023Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	246000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Past Due FinancingReceivableExcludingAccruedInterestPastDue	4358000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2639000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	442000	usd
CY2022Q4	opbk	Financing Receivable Excluding Accrued Interest Past Due FinancingReceivableExcludingAccruedInterestPastDue	3081000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1692485000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	52315000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	618291000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	294577000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	159976000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	197830000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	309803000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	59693000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1692485000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	11000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	91000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	14000	usd
CY2023Q1	opbk	Financing Receivable Excluding Accrued Interest Revolving Writeoff FinancingReceivableExcludingAccruedInterestRevolvingWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	116000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1678292000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	6400000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15847000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15269000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11200000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10869000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4647000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4400000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	371000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	390000	usd
CY2022Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	0	usd
CY2023Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	0	usd
CY2022Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12759000	usd
CY2021Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12720000	usd
CY2023Q1	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	961000	usd
CY2022Q1	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	1171000	usd
CY2023Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12898000	usd
CY2022Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	12341000	usd
CY2023Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	18000000	usd
CY2022Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	15200000	usd
CY2023Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	411600000	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	356200000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	530585000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	253451000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	22566000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	17224000	usd
CY2023Q1	opbk	Time Deposit Maturities Year Five And Thereafter TimeDepositMaturitiesYearFiveAndThereafter	294000	usd
CY2023Q1	us-gaap	Time Deposits TimeDeposits	824120000	usd
CY2023Q1	us-gaap	Deposit Liability Uninsured DepositLiabilityUninsured	900600000	usd
CY2023Q1	opbk	Uninsured Deposit Liability Percent UninsuredDepositLiabilityPercent	0.473
CY2022Q4	us-gaap	Deposit Liability Uninsured DepositLiabilityUninsured	938300000	usd
CY2022Q4	opbk	Uninsured Deposit Liability Percent UninsuredDepositLiabilityPercent	0.498
CY2023Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	50000000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.0527
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	67000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	67000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	680784000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3100000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.290
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.291
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	267801000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	270847000	usd
CY2023Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	11850000	usd
CY2022Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	12212000	usd
CY2023Q1	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	8635000	usd
CY2022Q4	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	8748000	usd
CY2023Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	361000	usd
CY2022Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	187000	usd
CY2023Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	456000	usd
CY2022Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	160000	usd
CY2023Q1	opbk	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	324000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	215000	usd
CY2023Q1	opbk	Employee Minimum Service Period EmployeeMinimumServicePeriod	P3M
CY2023Q1	opbk	Eligibility Age Of Employees For Plan EligibilityAgeOfEmployeesForPlan	P18Y
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	236000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	203000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	181509000	usd
CY2023Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	8046000	usd
CY2023Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1653450000	usd
CY2023Q1	opbk	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	7302000	usd
CY2023Q1	opbk	Time Deposits Placed Fair Value Disclosure TimeDepositsPlacedFairValueDisclosure	95000	usd
CY2023Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	18010000	usd
CY2023Q1	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1902346000	usd
CY2023Q1	opbk	Accrued Interest Payable Fair Value Disclosure AccruedInterestPayableFairValueDisclosure	5751000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	82972000	usd
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	47217000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1626036000	usd
CY2022Q4	opbk	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	7180000	usd
CY2022Q4	opbk	Time Deposits Placed Fair Value Disclosure TimeDepositsPlacedFairValueDisclosure	95000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	16845000	usd
CY2022Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1880508000	usd
CY2022Q4	opbk	Accrued Interest Payable Fair Value Disclosure AccruedInterestPayableFairValueDisclosure	2771000	usd
CY2023Q1	opbk	Risk Weighted Assets Capital Conservation Buffer Percentage RiskWeightedAssetsCapitalConservationBufferPercentage	0.025
CY2023Q1	us-gaap	Capital Capital	220207000	usd
CY2023Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1327
CY2023Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	200141000	usd
CY2023Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1206
CY2023Q1	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	200141000	usd
CY2023Q1	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1206
CY2023Q1	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	200141000	usd
CY2023Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0943
CY2022Q4	us-gaap	Capital Capital	213862000	usd
CY2022Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1306
CY2022Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	194358000	usd
CY2022Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1187
CY2022Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	194358000	usd
CY2022Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1187
CY2022Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	194358000	usd
CY2022Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0938
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7534000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8152000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	159000	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	142000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7375000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8010000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15284350	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15137808	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7375000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8010000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15284350	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15137808	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	28323	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	104406	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15312673	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15242214	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001628280-23-018156-index-headers.html	Edgar Link	pending
0001628280-23-018156-index.html	Edgar Link	pending
0001628280-23-018156.txt	Edgar Link	pending
0001628280-23-018156-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opbk-20230331.htm	Edgar Link	pending
opbk-20230331.xsd	Edgar Link	pending
opbk-20230331x10qexx311.htm	Edgar Link	pending
opbk-20230331x10qexx312.htm	Edgar Link	pending
opbk-20230331x10qexx321.htm	Edgar Link	pending
opbk-20230331x10qexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
opbk-20230331_cal.xml	Edgar Link	unprocessable
opbk-20230331_def.xml	Edgar Link	unprocessable
opbk-20230331_pre.xml	Edgar Link	unprocessable
opbk-20230331_lab.xml	Edgar Link	unprocessable
opbk-20230331_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPBK
OP Bancorp Stock $opbk

2023 Q2 Form 10-Q Financial Statement

#000162828023018156 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPBK OP Bancorp Stock $opbk

2023 Q2 Form 10-Q Financial Statement

#000162828023018156 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPBK
OP Bancorp Stock $opbk